David Jans | Member Profile | VIIN

< BACK TO FIND A MEMBER

Prof David Jans

Head Nuclear Signalling Lab
Department of Biochemistry and Molecular Biology
Monash University

david.jans@monash.edu

Licensing opportunities

Antiviral drug discovery platform:
http://www.monash.edu/industry/capabilities-technology/licensing#anti-viral
Drug therapy for dengue fever:
industry/capabilities-technology/licensing#dengue" rel="nofollow" target="_blank">http://www.monash.edu/industry/capabilities-technology/licensing#dengue

SEE MORE DETAIL | EMAIL ENQUIRY >

Research Activities

Nucleocytoplasmic transport of viral proteins: implications for disease
Viruses: DENV, RSV, Rhinovirus, HIV-1, Hendra, VEEV

Techniques/Expertise

Cell biology, Nuclear transport, Virus pathogenesis, FRAP

Collaborations

Numerous national and international collaborations.

Disease Models

INTEREST in mouse models for DENV and RSV

Genetically Modified Organisms

Various

Other Lab Members

Leon Caly
Kylie Wagstaff
Alex Martin
Hong-Mei Li
Christina Wang

Other members with similar research interests

Dr Justine Mintern

Department of Biochemistry and Molecular Biology University of Melbourne SEE FULL PROFILE >

Prof Stephen Locarnini

Research and Molecular Development Victorian Infectious Diseases Reference Laboratory SEE FULL PROFILE >

Prof Steven Gerondakis

Australian Centre for Blood Diseases Monash University SEE FULL PROFILE >

Jun 3

7th International Symposium on Antimicrobial Peptides (AMP2020)
Institut Pasteur MORE INFO
Jun 3

Australasian Society for Infectious Diseases (ASID) Annual Scientific Meeting 2020
Pullman Melbourne on the Park MORE INFO
Jun 3

Impact of Environmental Changes on Infectious Diseases (IECID) 2020
James Cook University, Singapore